---
title: "Cytomed Therapeutics (GDTC.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/GDTC.US/norm.md"
symbol: "GDTC.US"
name: "Cytomed Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/GDTC.US.md"
datetime: "2026-03-15T14:37:24.438Z"
locales:
  - [en](https://longbridge.com/en/quote/GDTC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GDTC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GDTC.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/GDTC.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GDTC.US/norm.md)


# Cytomed Therapeutics (GDTC.US) — 财务报表

## 利润表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0762 | -0.0725 | -0.0455 | -0.0483 | -0.0348 |
| ROE | -62.79% | -55.70% | -31.86% | -29.87% | -21.42% |
| Revenue | 176544.37 | 167965.86 | 102600.40 | 109031.41 | 82666.64 |
| Net income | -878933.88 | -836225.40 | -524894.16 | -557794.60 | -401344.45 |
| Operating income | -798279.55 | -759490.16 | -545524.64 | -579718.19 | -606991.46 |
| Gross margin | 94.28% | 94.28% | 89.67% | 89.67% | 99.02% |
| Net margin | -497.85% | -497.85% | -511.59% | -511.59% | -485.50% |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.55M | 6.23M | 7.40M | 7.86M | 8.05M |
| Leverage | 1.16 | 1.16 | 1.11 | 1.11 | 1.07 |
| BVPS | 0.4852 | 0.4616 | 0.5711 | 0.6068 | 0.6494 |
| Turnover | 0.0758 | 0.0640 | 0.0449 | 0.0424 | 0.0361 |
| Cash & STI | 2.24M | 2.13M | 3.65M | 3.88M | 5.03M |
| Inv & Rec | 659420.56 | 627378.50 | 616529.22 | 655173.36 | 530171.69 |
| LT assets | 2.72M | 2.59M | 2.39M | 2.54M | 1.83M |
| Net debt | -1.85M | -1.76M | -3.31M | -3.52M | -4.72M |

## 现金流量表 (USD)

| 指标 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -626430.38 | -595991.35 | -571107.49 | -606904.58 | -426227.56 |
| Investing CF | -8839.64 | -8410.11 | 1.11M | 1.18M | -696118.56 |
| Financing CF | -13659.40 | -12995.68 | -12990.97 | -13805.25 | -10893.55 |
| Free CF | -389246.40 | -454789.06 | -493768.74 | -450849.40 | -653438.94 |
| OCF coverage | -429.47% | -429.47% | -301.78% | -301.78% | -124.31% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -136240.71 | -129620.60 | -180114.07 | -191403.64 | -335601.87 |